Conclusion
The results show that preoperative intravenous tranexamic acid reduces
the total blood loss irrespective of the route of hysterectomy and the
number of perioperative transfusions. No incidences of serious adverse
events occurred. Thus, tranexamic acid should be considered as a
prophylactic treatment before benign hysterectomy.
Keywords:Anti-fibrinolytic
therapy,
Benign
hysterectomy,
Bleeding
complication,
Hysterectomy,
Tranexamic acid